Is smoking an indirect risk factor for the development of ulcerative colitis? An age‐ and sex‐matched case–control study
- 24 January 2003
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 18 (2), 139-146
- https://doi.org/10.1046/j.1440-1746.2003.02953.x
Abstract
Background: It has been suggested that smoking protects against the development of ulcerative colitis (UC). Evidence is mainly driven from the way data from a multitude of case–control studies have been interpreted. Methods: An age‐ and sex‐matched case–control study was conducted to further assess the association between history of smoking, past surgery, childhood, and other potential causative factors with the development of UC using the answers to a detailed questionnaire. The data were analyzed using univariate analysis and logistic regression. The results are presented as odds ratios (OR) and 95% confidence intervals. Results: One hundred and two cases and an equal number of matched controls were included in the study. Using a three‐level comparison, at the age of diagnosis, the risks of developing UC were 0.41 (0.19–0.87), 3.45 (1.62–7.35) and 0.78 (0.44–1.37) for smokers, ex‐smokers and non‐smokers, respectively. When compared to individuals who have never smoked, ex‐smokers were at a higher risk of developing the disease (OR = 3.00 (1.38–6.51)). The specific history of quitting smoking prior to the age of onset of symptoms was associated with an increased risk for developing the disease (OR = 3.45 (1.62–7.35)). Conclusions: Active smoking was associated with a low risk for the development of UC, but the lack of history of smoking was not associated with an increase in the risk. History of quitting smoking prior to the onset of symptoms, in contrast, was associated with a significant increase in the risk of developing the disease. These findings make the theory of a simple protective effect of smoking on the development of UC difficult to justify. It may be plausible to suggest that the withdrawal of the immunosuppressive effect of smoking triggers the disease onset in a genetically susceptible individual or simply unmasks its symptoms.Keywords
This publication has 35 references indexed in Scilit:
- Do pANCA define a clinical subgroup in patients with Crohn's disease?Gastroenterology, 1997
- The role of cigarettes and nicotine in the onset and treatment of ulcerative colitisPostgraduate Medical Journal, 1996
- Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?European Journal of Gastroenterology & Hepatology, 1996
- Lack of association between smoking and inflammatory bowel disease in Jewish patients in IsraelGastroenterology, 1995
- Measles virus in Crohn's diseaseThe Lancet, 1995
- Risk Indicators for Inflammatory Bowel DiseaseInternational Journal of Epidemiology, 1993
- Investigations on etiology of Crohn's diseaseDigestive Diseases and Sciences, 1991
- Aetiology and pathogenesis of ulcerative colitis and Crohn’s diseasePublished by Oxford University Press (OUP) ,1989
- Prevalence of atopy is unrelated to presence of inflammatory bowel diseaseClinical and Experimental Allergy, 1988
- The experimental paradigm and observational studies of cause-effect relationships in clinical medicineJournal of Chronic Diseases, 1987